Purchase Order 36C26326P0200

Edwards Lifesciences LLC was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on January 12, 2026, for transcatheter aortic valve replacement (TAVR) medical devices. The contract, which carries no set-aside designation, is scheduled for completion by February 11, 2026, with performance taking place in Minneapolis, Minnesota. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease treatment, the contractor supplies specialized cardiovascular medical devices exclusively to the U.S. Department of Veterans Affairs across multiple VISNs to support veteran healthcare needs.

This purchase order represents a typical transaction within Edwards Lifesciences LLC's established relationship with the VA, where the company serves as the sole manufacturer and prime contractor for advanced heart valve technologies. The company holds two significant Indefinite Delivery Contracts with the VA valued at $2.5 million and $1.25 million respectively, which allow the VA to maintain these short shelf-life cardiac devices in inventory for surgical procedures. Edwards Lifesciences LLC is recognized as a self-certified small disadvantaged business, and this purchase order falls within the company's standard contracting range of $11,000 to $102,000 for specialized cardiovascular products supporting the federal healthcare system.